177 related articles for article (PubMed ID: 21415236)
1. Metabolic syndrome and the risk of breast cancer in postmenopausal women.
Rosato V; Bosetti C; Talamini R; Levi F; Montella M; Giacosa A; Negri E; La Vecchia C
Ann Oncol; 2011 Dec; 22(12):2687-2692. PubMed ID: 21415236
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome, insulin resistance, and mammographic density in pre- and postmenopausal women.
Kim BK; Chang Y; Ahn J; Jung HS; Kim CW; Yun KE; Kwon MJ; Suh BS; Chung EC; Shin H; Ryu S
Breast Cancer Res Treat; 2015 Sep; 153(2):425-34. PubMed ID: 26277917
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and endometrial cancer risk.
Rosato V; Zucchetto A; Bosetti C; Dal Maso L; Montella M; Pelucchi C; Negri E; Franceschi S; La Vecchia C
Ann Oncol; 2011 Apr; 22(4):884-889. PubMed ID: 20937645
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and the risk of breast cancer among postmenopausal women in North-West China.
Wang M; Cheng N; Zheng S; Wang D; Hu X; Ren X; Pei H; Ma H; Mu H; Bai Y
Climacteric; 2015; 18(6):852-8. PubMed ID: 26507498
[TBL] [Abstract][Full Text] [Related]
5. Risk of metabolic syndrome in postmenopausal breast cancer survivors.
Buttros Dde A; Nahas EA; Vespoli Hde L; Uemura G; de Almeida Bda R; Nahas-Neto J
Menopause; 2013 Apr; 20(4):448-54. PubMed ID: 23149866
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome as a predictor of endometrial polyps in postmenopausal women.
Bueloni-Dias FN; Spadoto-Dias D; Delmanto LR; Nahas-Neto J; Nahas EA
Menopause; 2016 Jul; 23(7):759-64. PubMed ID: 27116465
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study.
Agnoli C; Berrino F; Abagnato CA; Muti P; Panico S; Crosignani P; Krogh V
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):41-8. PubMed ID: 19361966
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and breast cancer risk: a case-cohort study nested in a multicentre italian cohort.
Agnoli C; Grioni S; Sieri S; Sacerdote C; Ricceri F; Tumino R; Frasca G; Pala V; Mattiello A; Chiodini P; Iacoviello L; De Curtis A; Panico S; Krogh V
PLoS One; 2015; 10(6):e0128891. PubMed ID: 26030767
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies.
Hallajzadeh J; Khoramdad M; Izadi N; Karamzad N; Almasi-Hashiani A; Ayubi E; Qorbani M; Pakzad R; Hasanzadeh A; Sullman MJM; Safiri S
Menopause; 2018 Oct; 25(10):1155-1164. PubMed ID: 29787477
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women.
Kabat GC; Kim MY; Lee JS; Ho GY; Going SB; Beebe-Dimmer J; Manson JE; Chlebowski RT; Rohan TE
Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1730-1735. PubMed ID: 28939589
[No Abstract] [Full Text] [Related]
11. The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis.
Zhao P; Xia N; Zhang H; Deng T
Obes Facts; 2020; 13(4):384-396. PubMed ID: 32698183
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it.
Ruan X; Jin J; Hua L; Liu Y; Wang J; Liu S
Menopause; 2010; 17(3):566-70. PubMed ID: 20054286
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study.
Arthur RS; Kabat GC; Kim MY; Wild RA; Shadyab AH; Wactawski-Wende J; Ho GYF; Reeves KW; Kuller LH; Luo J; Beebe-Dimmer J; Simon MS; Strickler H; Wassertheil-Smoller S; Rohan TE
Cancer Causes Control; 2019 Apr; 30(4):355-363. PubMed ID: 30788634
[TBL] [Abstract][Full Text] [Related]
15. Hypertension and hormone-related neoplasms in women.
Soler M; Chatenoud L; Negri E; Parazzini F; Franceschi S; la Vecchia C
Hypertension; 1999 Aug; 34(2):320-5. PubMed ID: 10454461
[TBL] [Abstract][Full Text] [Related]
16. Associations of postmenopausal hormone therapy with metabolic syndrome among diabetic and non-diabetic women.
Kim JE; Choi J; Park J; Lee JK; Shin A; Park SM; Kang D; Choi JY
Maturitas; 2019 Mar; 121():76-82. PubMed ID: 30704569
[TBL] [Abstract][Full Text] [Related]
17. [Metabolic syndrome in postmenopausal breast cancer survivors].
Nahas EA; de Almeida Bda R; Buttros Dde A; Véspoli Hde L; Uemura G; Nahas-Neto J
Rev Bras Ginecol Obstet; 2012 Dec; 34(12):555-62. PubMed ID: 23329285
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
19. The Relation Between Metabolic Syndrome and Its Components with Breast Density in Postmenopausal Women.
Kaya C; Cengiz H; Alay İ; Örs S; Kaya SE; Ekin M; Yaşar L
Metab Syndr Relat Disord; 2019; 17(6):341-345. PubMed ID: 31045476
[No Abstract] [Full Text] [Related]
20. Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort.
Reeves KW; McLaughlin V; Fredman L; Ensrud K; Cauley JA
Cancer Causes Control; 2012 Aug; 23(8):1241-51. PubMed ID: 22661101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
